BIOSECURE returns to US pharma agenda with 2.0 update
The latest amendment, which has been endorsed by Congress, could be the Act’s catalyst after a year in legislative limbo.

The latest amendment, which has been endorsed by Congress, could be the Act’s catalyst after a year in legislative limbo.
During HUAWEI CONNECT 2025, Leo Chen, Senior Vice President, President of Enterprise Sales, Huawei, emphasised the focus is on how to harness AI’s full potential.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
First responders see AI and other advanced tech as essential
What does the EU Data Act mean for businesses?
Trump blames Covid-19 drugmakers for fuelling CDC turmoil
Oxford University and Ellison Institute link for AI vaccine research